Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia	Hemic and Lymphatic Diseases, Leukemia, Myelomonocytic, Acute, Neoplasms by Histologic Type, acute basophilic leukemia, acute monocytic leukemia, acute myeloid leukemia, adult acute monocytic leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm, therapy related acute myeloid leukemia and myelodysplastic syndrome	Active, not recruiting	Phase 2	2026-04-27		NCT01627041

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
National Cancer Institute (NCI)	3015

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Case Western Reserve University	Cleveland	United States	219
Lafayette Family Cancer Center-EMMC	Brewer	United States	97
Memorial Sloan Kettering Cancer Center	New York	United States	1000
Montefiore Medical Center - Moses Campus	The Bronx	United States	219
Montefiore Medical Center-Weiler Hospital	The Bronx	United States	109
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center	New York	United States	189
NYP/Weill Cornell Medical Center	New York	United States	128
Ohio State University Comprehensive Cancer Center	Columbus	United States	548
Roswell Park Cancer Institute	Buffalo	United States	382